Terms: = Endocrine gland cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Treatment
43 results:
1. hmga2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells.
Luo Z; Zheng Q; Ye S; Li Y; Chen J; Fan C; Chen J; Lei Y; Liao Q; Xi Y
Cell Death Dis; 2024 Mar; 15(3):220. PubMed ID: 38493165
[TBL] [Abstract] [Full Text] [Related]
2. Transformer 2β regulates the alternative splicing of cell cycle regulatory genes to promote the malignant phenotype of ovarian cancer.
Zhou T; Fu P; Chen D; Liu R
Oncol Res; 2023; 31(5):769-785. PubMed ID: 37547760
[TBL] [Abstract] [Full Text] [Related]
3. Unraveling the Roles of miR-204-5p and hmga2 in Papillary Thyroid cancer Tumorigenesis.
Van Branteghem C; Augenlicht A; Demetter P; Craciun L; Maenhaut C
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445942
[TBL] [Abstract] [Full Text] [Related]
4. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
5. A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis.
Chen L; Zhang X; Zhang Q; Zhang T; Xie J; Wei W; Wang Y; Yu H; Zhou H
Front Immunol; 2022; 13():1022420. PubMed ID: 36275722
[TBL] [Abstract] [Full Text] [Related]
6. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.
Ding C; Shi T; Wu G; Man J; Han H; Cui Y
Bioengineered; 2022 Mar; 13(3):6629-6640. PubMed ID: 35213273
[TBL] [Abstract] [Full Text] [Related]
7. Role of M2-like macrophages in the progression of ovarian cancer.
Baek SH; Lee HW; Gangadaran P; Oh JM; Zhu L; Rajendran RL; Lee J; Ahn BC
Exp Cell Res; 2020 Oct; 395(2):112211. PubMed ID: 32755554
[TBL] [Abstract] [Full Text] [Related]
8. MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC.
Sun C; Cao W; Qiu C; Li C; Dongol S; Zhang Z; Dong R; Song K; Yang X; Zhang Q; Kong B
J Hematol Oncol; 2020 Jan; 13(1):9. PubMed ID: 32005272
[TBL] [Abstract] [Full Text] [Related]
9. MiR-497 inhibits cell proliferation and invasion ability by targeting hmga2 in pancreatic ductal adenocarcinoma.
Zhou ZG; Xu C; Dong Z; Wang YP; Duan JY; Yan CQ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):122-129. PubMed ID: 31957824
[TBL] [Abstract] [Full Text] [Related]
10. Proteomic analysis of the papillary thyroid microcarcinoma.
Jin S; Bao W; Yang YT; Fu Q; Bai Y; Liu Y
Ann Endocrinol (Paris); 2019 Nov; 80(5-6):293-300. PubMed ID: 31606199
[TBL] [Abstract] [Full Text] [Related]
11. RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.
D'Angelo D; Mussnich P; Sepe R; Raia M; Del Vecchio L; Cappabianca P; Pellecchia S; Petrosino S; Saggio S; Solari D; Fraggetta F; Fusco A
J Mol Med (Berl); 2019 Jul; 97(7):1019-1032. PubMed ID: 31076808
[TBL] [Abstract] [Full Text] [Related]
12. CXCL12-regulated miR-370-3p functions as a tumor suppressor gene by targeting hmga2 in nonfunctional pituitary adenomas.
Cai F; Dai C; Chen S; Wu Q; Liu X; Hong Y; Wang Z; Li L; Yan W; Wang R; Zhang J
Mol Cell Endocrinol; 2019 May; 488():25-35. PubMed ID: 30853598
[TBL] [Abstract] [Full Text] [Related]
13. Tunneling Nanotubular Expressways for Ultrafast and Accurate M1 Macrophage Delivery of Anticancer Drugs to Metastatic Ovarian Carcinoma.
Guo L; Zhang Y; Yang Z; Peng H; Wei R; Wang C; Feng M
ACS Nano; 2019 Feb; 13(2):1078-1096. PubMed ID: 30608136
[TBL] [Abstract] [Full Text] [Related]
14. hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance.
Chiou SH; Dorsch M; Kusch E; Naranjo S; Kozak MM; Koong AC; Winslow MM; Grüner BM
Sci Rep; 2018 Sep; 8(1):14008. PubMed ID: 30228296
[TBL] [Abstract] [Full Text] [Related]
15. GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical liposomal Formulation for Ovarian cancer treatment.
Zou Y; Xia Y; Meng F; Zhang J; Zhong Z
Mol Pharm; 2018 Sep; 15(9):3664-3671. PubMed ID: 29570299
[TBL] [Abstract] [Full Text] [Related]
16. CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic cancer Cells Through Targeting hmga2.
Xiao G; Wang X; Yu Y
Cell Physiol Biochem; 2017; 43(2):840-851. PubMed ID: 28954272
[TBL] [Abstract] [Full Text] [Related]
17. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular hmga2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract] [Full Text] [Related]
18. Stroma-regulated hmga2 is an independent prognostic marker in PDAC and AAC.
Strell C; Norberg KJ; Mezheyeuski A; Schnittert J; Kuninty PR; Moro CF; Paulsson J; Schultz NA; Calatayud D; Löhr JM; Frings O; Verbeke CS; Heuchel RL; Prakash J; Johansen JS; Östman A
Br J Cancer; 2017 Jun; 117(1):65-77. PubMed ID: 28524160
[TBL] [Abstract] [Full Text] [Related]
19. TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling.
Roberts CM; Tran MA; Pitruzzello MC; Wen W; Loeza J; Dellinger TH; Mor G; Glackin CA
Sci Rep; 2016 Nov; 6():37652. PubMed ID: 27876874
[TBL] [Abstract] [Full Text] [Related]
20. A liposomal formulation of the synthetic curcumin analog EF24 (lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
Bisht S; Schlesinger M; Rupp A; Schubert R; Nolting J; Wenzel J; Holdenrieder S; Brossart P; Bendas G; Feldmann G
J Nanobiotechnology; 2016 Jul; 14(1):57. PubMed ID: 27401816
[TBL] [Abstract] [Full Text] [Related]
[Next]
